Literature DB >> 9061668

Animal models of cutaneous lupus erythematosus and lupus erythematosus photosensitivity.

F Furukawa1.   

Abstract

Over the past decade, the most exciting and important finding in SLE-prone mice is the discovery of Fas/Fas ligand systems in the pathogenesis of autoimmune phenomena. A human model for murine lpr/gld disease has also been reported recently. Furthermore, as shown in Table 2, studies on Ig variable region genes, TCR genes and MHC class II genes have given us much information concerning human and murine SLE. With respect to cytokines, IL-2 deficiency and the key role of IL-6 have been found in SLE-prone mouse strains, and Th2 cytokine production has been demonstrated to play a more pathogenic role than Th1 cytokine production in human and murine SLE except for MRL/pr mice. TGF is also very intriguing because TGF-beta knockout mice show SLE-like autoantibodies and Sjögren syndrome-like lymphoproliferation. Apart from these basic scientific investigations, there are also many promising and practical therapeutic approaches. In particular, treatments with anti-CD4 antibody and murine CTLA4Ig which bound B7 and blocked binding of CD28 to B7 are outstanding. However, it remains obscure whether such new approaches are effective for the skin lesions of SLE-prone mice, although some immunosuppressive agents such as FK506, cyclosporin and Chinese herbal medicines have been evaluated to determine their selective effects on the skin lesions of MRL/lpr mice. Needless to say, mouse models are not identical, but similar, to human diseases. However, they are important in the search for the underlying pathogenesis of autoimmune diseases on the basis of careful evaluation of the similarities and differences between human diseases and these models. If such studies are steadily performed, then inbred or experimental models will become more promising tools for the investigation of cutaneous lupus erythematosus.

Entities:  

Mesh:

Year:  1997        PMID: 9061668     DOI: 10.1177/096120339700600215

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  11 in total

Review 1.  Use of localised gene transfer to develop new treatment strategies for the salivary component of Sjögren's syndrome.

Authors:  M R Kok; B J Baum; P P Tak; S R Pillemer
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

2.  Ruxolitinib Attenuates Cutaneous Lupus Development in a Mouse Lupus Model.

Authors:  Emilie S Chan; Leal C Herlitz; Ali Jabbari
Journal:  J Invest Dermatol       Date:  2015-03-19       Impact factor: 8.551

Review 3.  Animal models of skin disease for drug discovery.

Authors:  Pinar Avci; Magesh Sadasivam; Asheesh Gupta; Wanessa Cma De Melo; Ying-Ying Huang; Rui Yin; Rakkiyappan Chandran; Raj Kumar; Ayodeji Otufowora; Theodore Nyame; Michael R Hamblin
Journal:  Expert Opin Drug Discov       Date:  2013-01-08       Impact factor: 6.098

4.  Interleukin (IL)-39 [IL-23p19/Epstein-Barr virus-induced 3 (Ebi3)] induces differentiation/expansion of neutrophils in lupus-prone mice.

Authors:  X Wang; X Liu; Y Zhang; Z Wang; G Zhu; G Han; G Chen; C Hou; T Wang; N Ma; B Shen; Y Li; H Xiao; R Wang
Journal:  Clin Exp Immunol       Date:  2016-08-12       Impact factor: 4.330

5.  Foxd3 suppresses interleukin-10 expression in B cells.

Authors:  Yu Zhang; Zhiding Wang; He Xiao; Xiaoling Liu; Gaizhi Zhu; Dandan Yu; Gencheng Han; Guojiang Chen; Chunmei Hou; Ning Ma; Beifen Shen; Yan Li; Tianxiao Wang; Renxi Wang
Journal:  Immunology       Date:  2017-01-12       Impact factor: 7.397

6.  Susceptibility of T cell receptor-alpha chain knock-out mice to ultraviolet B light and fluorouracil: a novel model for drug-induced cutaneous lupus erythematosus.

Authors:  T Yoshimasu; T Nishide; N Seo; A Hiroi; T Ohtani; K Uede; F Furukawa
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

7.  B cells regulate thymic CD8+T cell differentiation in lupus-prone mice.

Authors:  Chen Xing; Gaizhi Zhu; He Xiao; Ying Fang; Xiaoling Liu; Gencheng Han; Guojiang Chen; Chunmei Hou; Beifen Shen; Yan Li; Ning Ma; Renxi Wang
Journal:  Oncotarget       Date:  2017-07-05

8.  Anti‑IL‑39 (IL‑23p19/Ebi3) polyclonal antibodies ameliorate autoimmune symptoms in lupus‑like mice.

Authors:  Xiaoqian Wang; Yu Zhang; Zhiding Wang; Xiaoling Liu; Gaizhi Zhu; Gencheng Han; Guojiang Chen; Chunmei Hou; Tianxiao Wang; Beifen Shen; Yan Li; He Xiao; Ning Ma; Renxi Wang
Journal:  Mol Med Rep       Date:  2017-11-14       Impact factor: 2.952

9.  Contribution of V(H) replacement products in mouse antibody repertoire.

Authors:  Lin Huang; Miles D Lange; Yangsheng Yu; Song Li; Kaihong Su; Zhixin Zhang
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

Review 10.  Pathophysiology of cutaneous lupus erythematosus.

Authors:  Julie H Lin; Jan P Dutz; Richard D Sontheimer; Victoria P Werth
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 10.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.